Offering image-guided superficial radiation therapy to rural populations could mend health disparities in nonmelanoma skin cancer treatment, according to a study published in Cancers.Historically, ...

A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.

Lake Street initiated coverage of Sensus Healthcare (SRTS) with a Buy rating and $18 price target Sensus’ superficial radiation therapy is a non-invasive treatment with no surgical scarring or need ...

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally ...

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally ...

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to treat surgically. A ...

The results published in the top journal Nature Cancer could improve the treatment of superficial tumors such as melanoma and breast cancer. In recent years, immunotherapies have had significant ...

Women were a younger mean age at melanoma diagnosis when compared with men across all anatomic sites and most Breslow thickness categories.

A study highlights the effectiveness of Talimogene laherparepvec (TVEC) for basal cell carcinoma. The virus-based therapy ...

Researchers at MedUni Vienna have developed a combination therapy using systemic interferon-I and topical imiquimod.

In the study, TVEC was used, which has so far only been approved for the treatment of superficial melanoma metastases. TVEC is a genetically modified herpes simplex virus that specifically ...

In the study Talimogene Laherparepvec (TVEC) was used, which has so far only been approved for the treatment of superficial melanoma metastases. TVEC is a genetically modified herpes simplex virus ...